Vertex Pharmaceuticals saw the highest growth of 169% in patent filings and 221% in grants in March in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 86% and grants by 172%. GlobalData’s DataBook provides a comprehensive analysis of Vertex Pharmaceuticals‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Vertex Pharmaceuticals has been focused on protecting inventions in China(CN) with 19 publications in Q1 2024

The China(CN) Patent Office dominates the patent filings and grants with nearly 17% filings and 20% grants. The China(CN), United States(US), Israel(IL), and European Patent Office(EPO) patent Office are among the top ten patent offices where Vertex Pharmaceuticals is filings its patents. Among the top granted patent authorities, Vertex Pharmaceuticals has 20% of its grants in China(CN), 18% in United States(US) and 15% in Canada(CA).

F. Hoffmann-La Roche could be the strongest competitor for Vertex Pharmaceuticals

Patents related to rare diseases and cell & gene therapy lead Vertex Pharmaceuticals's portfolio

Vertex Pharmaceuticals has the highest number of patents in rare diseases followed by, cell & gene therapy and genomics. For rare diseases, nearly 61% of patents were filed and 70% of patents were granted in Q1 2024.

Cystic fibrosis related patents lead Vertex Pharmaceuticals portfolio followed by fibrosis, and pain

Vertex Pharmaceuticals has highest number of patents in cystic fibrosis followed by fibrosis, pain, petrochemicals, and macular degeneration. For cystic fibrosis, nearly 10% of patents were filed and 25% of patents were granted in Q1 2024.

For comprehensive analysis of Vertex Pharmaceuticals's filings and grants, buy the databook here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.